🔎 Trials Near Me

Akèy › Dematit atopik (Ekzema) › Indiana › Indianapolis

Etid klinik pou Dematit atopik (Ekzema) nan Indianapolis, IN

7 etid pou Dematit atopik (Ekzema) ap chèche patisipan nan sit nan ak bò kote Indianapolis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

Ap rekriteFaz 1Volontè an sante akeyi
  • Clinical Site 106, Plainfield · 14 mi lwen
Laj 18 a 65 · Tout sèks · Mizajou Sep 29, 2026 · NCT07453602

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Ap rekriteFaz 3
  • Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Laj 2 a 11 · Tout sèks · Mizajou Sep 25, 2026 · NCT06807281

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

Ap rekriteFaz 2
  • Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Laj 18 a 65 · Tout sèks · Mizajou Aug 28, 2026 · NCT07599813

A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Ap rekriteFaz 2
  • Enveda Investigative Site, Indianapolis
  • Enveda Investigative Site, Plainfield · 14 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07643766

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

Ap rekriteFaz 2
  • Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou May 4, 2026 · NCT05995964

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Ap rekriteEtid obsèvasyon
  • Galderma Investigational Site 8142, Indianapolis
Laj 12 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT06988605

Etid Dematit atopik (Ekzema) nan lòt vil

Lòt etid nan Indianapolis

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.